Purple Biotech Ltd.

Regulatory Filings • Apr 12, 2022

Complementary Report for a report sent on 11/04/2022 whose reference number was 2022-02-046528.Main details added/ completed:This Complementary Repo false

���� ����� ��"�	2 380
PURPLE BIOTECH LTD
Corporation no: 520031238	13936
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	11/04/2022
	www.isa.gov.il			www.tase.co.il				Reference:	2022-02-046813	Time of broadcast: 23:19 23:19

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onComplementary Report for a report sent on 11/04/2022 whose reference number was 2022-02-046528. Main details added/ completed:This Complementary Report amends the original report by including the Company�s Safe Harbor Statement in the press release, �Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the American Association of Cancer Research 2022 Annual Meeting�, which is attached hereto as Exhibit 99.1, and which replaces Exhibit 99.1 attached to the Original Report in its entirety. There are no other changes to the original report reflected in this Amended Report.

ea158313-6ka1_purplebioEDGAR1_Bannerless_isa.pdf

����� ���� ���� ���� ��� ���� ���� ������- AACR ���� ����� �� � CM 24 �� ����� ������ - ���� ����� ����� ������ ������� ���� ������ b1
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2022-02-046528
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 22/02/2022
Address: Oppenheimer, Science Park 4 , Rehovot 7670104   , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196
E-mail address: ir@purple-biotech.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: Livneh Nir Position of Signatory in the reporting corporation: Vice President & General Counsel Name of Employer Company:
Address: Oppenheimer 4 , Rehovot 7670104 Telephone: 050-5611024 Facsimile: 03-5097196 E-mail: nirl@purple-biotech.com 1
Israel